Attorney General Raoul Announces $102.5 Million Settlement With Suboxone Maker For Alleged Illegal Monopoly Tactics
CHICAGO - Attorney General Kwame Raoul announced Illinois and 41 other states negotiated a bipartisan nationwide $102.5 million settlement with Indivior Inc., a global pharmaceutical company and the maker of Suboxone, a prescription drug used to treat opioid addiction. Under the settlement , the state of Illinois is expected to receive approximately $2.9 million. In 2016, Illinois and the coalition states filed a complaint against Indivior with the U.S. District Court in the Eastern District of Pennsylvania, alleging the company used illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets to preserve its drug monopoly. Suboxone is a brand name prescription drug used to treat heroin and other opioid addictions by easing addiction cravings. “Our settlement with Indivior comes at a crucial time when too many people continue to battle addiction to opioids and need medications to treat opioid addiction,” Raoul said
stLouIST